TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TAP Biosystems Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12344
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a provider of laboratory and pharmaceutical equipment. The company designs and manufactures automated cell culture, bio-reactor systems and fermentation systems. It also provides labware, consumables and accessories. TAP offers services such as installation, onsite repair services, preventative maintenance, operator and maintenance training, system and software upgrades, preventive maintenance visits, lab relocations and decommissioning, protocol development, customer support, and validation and GMP compliance. The company’s products find application in drug discovery, biologics production, bioprocess development, regenerative medicine and tissue engineering. It partners with distribution companies. It has operations in Royston, the UK; and Wilmington, the US. TAP is headquartered in Royston, the UK.

TAP Biosystems Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
Licensing Agreements 16
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Acquisition 17
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd – Key Competitors 19
TAP Biosystems Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd, Key Competitors 19
TAP Biosystems Ltd, Other Locations 20

List of Figures
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • H2O Retailing Corporation:企業の戦略・SWOT・財務情報
    H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report Summary H2O Retailing Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Barclays Bank Plc:企業のM&A・事業提携・投資動向
    Barclays Bank Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barclays Bank Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Transportadora De Gas Del Sur S.A.:企業の戦略・SWOT・財務分析
    Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • ObsEva SA (OBSV):企業の財務・戦略的SWOT分析
    ObsEva SA (OBSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Alta Mesa Resources Inc:企業の戦略的SWOT分析
    Alta Mesa Resources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Telecom Egypt Company
    Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report Summary Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Export-Import Bank of Korea:電力:M&Aディール及び事業提携情報
    Summary The Export-Import Bank of Korea (Korea Eximbank) is a bank that offers financial products and services. The company’s products include loans, guarantees, bonds, trade finance products, investment products, and structured products. Its loan products comprise export related loans, overseas bus …
  • Nutreco NV:企業のM&A・事業提携・投資動向
    Nutreco NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nutreco NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Ichibanya Co Ltd:企業の戦略・SWOT・財務分析
    Ichibanya Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ichibanya Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Suda Pharmaceuticals Ltd (SUD):企業の財務・戦略的SWOT分析
    Summary Suda Pharmaceuticals Ltd (Suda Pharmaceuticals), formerly Suda Ltd is a drug delivery company that offers oro-mucosal administration solutions. The company offers products such as SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005, artimist, and zolpimist. Its artimist is a sub-lingual spray for …
  • Neurimmune Holding AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurimmune Holding AG (Neurimmune), formerly Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics for human diseases. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human neurodeg …
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務情報
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務情報
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Protege Energy III LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Protege Energy III LLC (Protege Energy) is an oil and gas exploration and production company. The company offers acquisition and development of oil and gas reserves including exploration, development, operations, horizontal drilling, reservoir stimulations, recompletions, artificial lift and …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Auris Medical Holding AG (EARS):企業の財務・戦略的SWOT分析
    Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Taragenyx Ltd:製品パイプライン分析
    Summary Taragenyx Ltd (Taragenyx) is a medical technology company that offers regenerative medicine technology, medical and biological engineering solutions. The company provides restorative implant solutions generation, burdensome operations, and medical, orthopedic and dental implantation solution …
  • Rafael Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), formerly Cornerstone Pharmaceuticals Inc, is a clinical-stage, metabolic oncology therapeutics company, which focuses to develop and commercialize cancer metabolism based drugs. The company’s lead drug candidate CPI-613 is designed to targ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆